1Chang LY,Lin TY,Hsu KH,et al.Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand,foot,and mouth disease[J].Lancet,1999,13,354(9191):1682-1686.
2Ho M,Chen ER,Hsu KH,et al.An epidemic of enterovirus 71 infection in Taiwan.Taiwan Enterovirus Epidemic Working Group [J ].N Engl J Med,1999,23,341 (13):929-935.
3Hsueh C,Jung SM,Shih SR,et al.Acute encephalomyelitis during an outbreak of enterovirus type 71 infection in Taiwan:report of an autopsy case with pathologic,immunofluorescence,and molecular studies[ J ].Mod Pathol,2000,13 (11):1200-1205.
4Wang SM,Liu CC,Tseng HW,et al.Clinical spectrum of enterovirus 71 infection in children in southern Taiwan,with an emphasis on neurological complications[J].Clin Infect Dis,1999,29(1):184-190.
5Chang LY,Hsia SH,Wu CT,et al.Outcome of infections with or without stage-based management:1998 to 2002 [ J ].Pediatric Infectious Disease Journal,2004,23 (4):327-332.
7Prager P,Nolan M,Andrews IP,et al.Neurogenic pulmonary edema in enterovirus 71 encephalitis is not uniformly fatal but causes severe morbidity in survivors [ J ].Pediatric Critical Care Medicine,2003,4(3):377-381.
8Huang YF,Chiu PC,Chen CC,et al.Cardiac Troponin I:A Reliable Marker and Early Myocardial Involvement with Meningoencephalitis after Fatal Enterovirus-71 Infection[J].The Journal of Infection,2003,46(4):238-243.
9Lin TY,Chang LY,Huang YC,et al.Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections:implications for early recognition and therapy[J].Acta Paediatr,2002,91(6):632-635.
10Sugaya N.Influenza-associated encephalopathy in Japan[J].Seminars in Pediatric Infection Disease,2002,13:79-84.
二级参考文献19
1Henter JI, Elinder G, Ost A, et al. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol, 1991; 18(1): 29.
2Kikuta H, Skiyama Y, Matsumoto S, et al. Fatal Epstein- Barr virusassociated hemophagocytic syndrome. Blood, 1993; 82( 11 ): 3259.
3Close P, Friedman D, Uri A. Viral- associated hemophagocytic syndrome. Med Pediatr Oncol, 1990; 18(2): 119.
4Kaito K, Kobyashi M, Katayama T, et al. Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol,1997; 59(4): 247.
5Gauvin F, Toledano B, Champagne J, et al. Reactive hemophagocytic syndrome presenting as a component of multiple organ dysfunction syndrome. Crit Care Med, 2000; 28(9): 3341.
6Fujiwara F, Hibi S, lmashuku S. Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol, 1993; 15(1): 92.
7Su IJ, Wang CH, Cheng AL, et al. Hemophagocytic syndrome in Epstein- Barr virus- associated T- lymphoproliferative disorders: disease spectrum, pathogenesis, and management. Leuk Lymphoma, 1995, 19(5 - 6): 401.
8Freeman B, Rathore MH, Salman E, et al. Intravenouly administered immune globulin for the treatment of infection - associated hemophagocytic syndrome. J Pediatr, 1993; 123(3): 479.
9Nagasawa M, Okawa H, Yata J, et al. Deleterious effects of high dose gamma- globulin therapy on patients with hemophagocytic syndrome. Int J Hematol, 1994; 60(1): 91.
10Imashuku S, Kuriyama K, Teramura T, et al. Requirement for etoposide in the treatment of Epstein - Bart virus - associated hemophagocytic lymphohistiocytosis. J Clin Oncol, 2001; 19(10): 2665.
